Retinal Vasculopathy with Cerebral Leukodystrophy Overview

Save information for later
Sign Up

Learn About Retinal Vasculopathy with Cerebral Leukodystrophy

What is the definition of Retinal Vasculopathy with Cerebral Leukodystrophy?
Retinal vasculopathy with cerebral leukodystrophy and systemic manifestations (RVCL-S) affects the small blood vessels in the central nervous system and other organs. Symptoms begin in adulthood and can include loss of vision, Raynaud's disease, kidney and liver disease, and cognitive problems that get worse over time. Other symptoms may include migraines, gastrointestinal bleeding, and hypothyroidism. RVCL-S is caused by genetic variations in the TREX1 gene, and is inherited in an autosomal dominant pattern. Diagnosis is based on the symptoms, clinical exam, imaging studies of the brain, and may be confirmed by the results of genetic testing.
What are the alternative names for Retinal Vasculopathy with Cerebral Leukodystrophy?
  • Retinal vasculopathy with cerebral leukodystrophy with systemic manifestations
  • Hereditary vascular retinopathy
  • ADRVCL
  • Autosomal Dominant Retinal Vasculopathy with Cerebral Leukodystrophy
  • CRV
  • Cerebroretinal vasculopathy, hereditary
  • RVCL
  • RVCL-S
  • Retinal vasculopathy and cerebral leukoencephalopathy
  • Retinopathy, vascular, with cerebral and renal involvement and Raynaud and migraine phenomena
  • HVR
Who are the top Retinal Vasculopathy with Cerebral Leukodystrophy Local Doctors?
Experienced in Retinal Vasculopathy with Cerebral Leukodystrophy
Dr. Matthew W. Manry
Ophthalmology
Experienced in Retinal Vasculopathy with Cerebral Leukodystrophy
Dr. Matthew W. Manry
Ophthalmology

Eye Care Center Of Northern Colorado, PC

1400 Dry Creek Dr, 
Longmont, CO 
 (23.5 mi)
303-772-3300
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Matthew Manry is an Ophthalmologist in Longmont, Colorado. Dr. Manry and is rated as an Experienced provider by MediFind in the treatment of Retinal Vasculopathy with Cerebral Leukodystrophy. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Neuroretinitis, and Geographic Atrophy. Dr. Manry is currently accepting new patients.

Experienced in Retinal Vasculopathy with Cerebral Leukodystrophy
Dr. Nora W. Muakkassa
Ophthalmology
Experienced in Retinal Vasculopathy with Cerebral Leukodystrophy
Dr. Nora W. Muakkassa
Ophthalmology

Eye Center Of Northern Colorado PC

13772 Denver W Pkwy, Suite 100, 
Lakewood, CO 
 (24.1 mi)
303-279-2600
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Nora Muakkassa is an Ophthalmologist in Lakewood, Colorado. Dr. Muakkassa and is rated as an Experienced provider by MediFind in the treatment of Retinal Vasculopathy with Cerebral Leukodystrophy. Her top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Central Serous Chorioretinopathy, and Retinal Vein Occlusion. Dr. Muakkassa is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Advanced in Retinal Vasculopathy with Cerebral Leukodystrophy
Dr. Frank S. Siringo
Ophthalmology
Advanced in Retinal Vasculopathy with Cerebral Leukodystrophy
Dr. Frank S. Siringo
Ophthalmology

Colorado Retina Associates, PLLC

255 S Routt St, Suite 200, 
Lakewood, CO 
 (26.5 mi)
303-261-1600
Languages Spoken:
English
See accepted insurances

Frank Siringo is an Ophthalmologist in Lakewood, Colorado. Dr. Siringo and is rated as an Advanced provider by MediFind in the treatment of Retinal Vasculopathy with Cerebral Leukodystrophy. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Geographic Atrophy, Late-Onset Retinal Degeneration, Vitrectomy, and Hormone Replacement Therapy (HRT).

View All Doctors
What are the latest Retinal Vasculopathy with Cerebral Leukodystrophy Clinical Trials?
Match to trials
Find the right clinical trials for you in under a minute
Get started
View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center